How should hyponatremia be managed in a patient with an adrenal mass?

Management of Hyponatremia in Patients with Adrenal Mass

All patients with an adrenal mass and hyponatremia must be screened for autonomous cortisol secretion using 1 mg dexamethasone suppression testing, and if adrenal insufficiency is confirmed or suspected, immediate hydrocortisone replacement is the definitive treatment that will correct the hyponatremia 1.

Initial Diagnostic Approach

The presence of hyponatremia with an adrenal mass requires urgent evaluation for hormone hypersecretion, as this combination suggests either adrenal insufficiency (from bilateral disease or autonomous cortisol secretion causing HPA axis suppression) or, less commonly, primary aldosteronism with concurrent issues.

Mandatory Hormonal Screening

Screen all patients with adrenal incidentalomas for:

• Autonomous cortisol secretion using 1 mg overnight dexamethasone suppression test (preferred screening test) 1
• Primary aldosteronism if hypertension or hypokalemia present (aldosterone-to-renin ratio) 1
• Pheochromocytoma if mass >10 HU on non-contrast CT or signs of catecholamine excess (plasma or 24-hour urinary metanephrines) 1

Critical Laboratory Assessment

Evaluate volume status and determine hyponatremia etiology:

• Serum osmolality, sodium, cortisol, ACTH
• Urine osmolality, urine sodium
• Assess for euvolemic vs. hypovolemic state
• Consider adrenal insufficiency even if basal cortisol appears "normal" (11-12 μg/dL range may be inadequate during stress) 2

Treatment Algorithm

If Adrenal Insufficiency is Confirmed or Strongly Suspected

Immediate hydrocortisone replacement normalizes hyponatremia by:

• Restoring normal vasopressin regulation
• Correcting inappropriate ADH secretion
• Improving renal free water clearance

Dosing:

• Acute/severe presentation: Hydrocortisone 100 mg IV, then continuous infusion of 200 mg/24 hours 3
• Stable outpatient: Standard replacement doses with stress-dose adjustments 4

Critical Safety Considerations During Correction

Monitor sodium correction rate meticulously - this is where mortality and morbidity occur:

• Maximum correction: 10 mEq/L in first 24 hours 5, 6, 7
• Target initial correction: 4-6 mEq/L within 1-2 hours for severely symptomatic patients 7
• Subsequent 18 hours: No more than 2 mmol/L additional increase 5

Common pitfall: Hydrocortisone can cause excessively rapid sodium correction by dramatically decreasing vasopressin levels and inducing massive dilute diuresis within 6 hours of administration 8. This creates risk of osmotic demyelination syndrome.

Prevention strategy:

• Check sodium every 2-4 hours initially
• If correction exceeds limits: administer 5% dextrose and desmopressin to slow correction 8
• Continue frequent monitoring until sodium reaches 131 mmol/L 5

Specific Scenarios

Bilateral adrenal masses with hyponatremia:

• High suspicion for adrenal insufficiency (lymphoma, metastases, hemorrhage, infiltration)
• Measure 17-hydroxyprogesterone to exclude congenital adrenal hyperplasia
• Assess for adrenal insufficiency even with "normal" cortisol 1, 2

Unilateral aldosterone-secreting adenoma:

• Paradoxically, underlying autonomous cortisol secretion may suppress HPA axis
• Under stress, can develop secondary adrenal insufficiency with severe hyponatremia 9
• Consider this diagnosis if unexplained clinical deterioration occurs

Pheochromocytoma:

• Rarely causes hyponatremia directly
• Screen to avoid hypertensive crisis during any intervention

Multidisciplinary Review Threshold

Obtain endocrinology, surgery, and radiology consultation when:

• Imaging inconsistent with benign lesion
• Evidence of hormone hypersecretion
• Hyponatremia with adrenal mass (suggests functional pathology)
• Adrenal surgery being considered 1

Definitive Management Based on Etiology

Cortisol-secreting masses with Cushing's syndrome:

• Unilateral adrenalectomy (minimally invasive when feasible) 1
• Post-operative glucocorticoid replacement for 6-18 months until HPA axis recovers 10

Aldosterone-secreting masses:

• Adrenal vein sampling before surgery 1
• Laparoscopic adrenalectomy 11
• Pre-operative treatment 8-10 weeks with spironolactone 100-200 mg/day to correct metabolic abnormalities 11

Pheochromocytoma:

• Alpha-blockade (phenoxybenzamine 10-20 mg BID, titrate up) for 1-3 weeks pre-operatively 10
• Never use beta-blockers before adequate alpha-blockade 11, 10
• Laparoscopic adrenalectomy 1, 11

Bilateral disease/adrenal insufficiency:

• Lifelong hydrocortisone replacement
• Patient education on stress dosing (double/triple doses during illness with fever) 4, 3
• Emergency injection kit and steroid emergency card at all times 3

Post-Treatment Monitoring

After correction of hyponatremia:

• Watch for refeeding syndrome (hypophosphatemia) if patient was malnourished 8
• Monitor for recurrence if underlying cause not definitively treated
• Annual hormonal screening for 5 years for non-resected masses 10

The key to preventing morbidity and mortality is recognizing that hyponatremia in the setting of an adrenal mass is a red flag for hormonal dysfunction requiring immediate systematic evaluation and cautious, monitored correction.